SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $806,598 | +5.9% | 6,654 | 0.0% | 0.02% | +18.8% |
| Q2 2023 | $762,016 | -16.9% | 6,654 | 0.0% | 0.02% | -20.0% |
| Q1 2023 | $917,121 | +10.8% | 6,654 | +4.1% | 0.02% | -16.7% |
| Q4 2022 | $827,887 | +72.8% | 6,389 | 0.0% | 0.02% | +60.0% |
| Q2 2022 | $479,000 | -4.0% | 6,389 | 0.0% | 0.02% | +15.4% |
| Q1 2022 | $499,000 | -13.2% | 6,389 | 0.0% | 0.01% | -13.3% |
| Q4 2021 | $575,000 | +11.4% | 6,389 | +10.9% | 0.02% | 0.0% |
| Q3 2021 | $516,000 | +22.3% | 5,759 | 0.0% | 0.02% | +7.1% |
| Q2 2021 | $422,000 | -1.6% | 5,759 | 0.0% | 0.01% | -6.7% |
| Q1 2021 | $429,000 | – | 5,759 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |